Qiagen last week rolled out its Array-Ready oligonucleotide set for the Xenopus tropicalis genome. The new set of oligos contains approximately 11,000 70-mer probes representing Xenopus transcripts from sequence and cluster data provided by Jim Smith of the Wellcome Trust/Cancer Research UK Gurdon Institute of Cancer and Developmental Biology in Cambridge, UK, which also beta tested the product. Each probe is melting-temperature normalized and includes a 5; amino linker for substrate attachment in microarray manufacturing. Annotation for the oligo set will be prov-ided on the Qiagen oligo microarray database. The product is provided in a 384-well plate format with 600 picomoles of probe per well. The set also includes a control plate with 24 controls (12 positive and 12 negative) in 16 replicates. Sample sets, which contain 96 optimized 70-mer probes in a 384-well format at 600 picomoles per well are also available, the company said. Pricing was not disclosed.
Finland’s Jurilab last week launched DrugMEt, a microarray-based genotyping test for the identification of genetically-mediated metabolic patterns in clinical trials. The test contains 27 SNPs from eight different enzymes and is designed to be used to genotype those thought to play a role in the metabolic pathways of many drugs. The product comes bundled with the company’s SnpRater software. Pricing was not disclosed.